Capstonethx
ShareCopied to clipboardCapstonethx is a company. It is a private company in Alsip, the United States. It was founded in 2008 and its current CEO is Matthew E. Lipman. It is part of the Materials sector, specifically in the Construction Materials industry.
Key facts
- city: Alsip
- country: United States
- employees: 46 people
- revenues: 44M $
- company type: private
- sector: Materials
- industry: Construction Materials
- foundation year: 2008
- CEO: Matthew E. Lipman
- ESG score: 69.43 / 100
See more facts
Extract data
Download datasets about Capstonethx:
Dataset of stocks from Capstonethx:
Capstonethx is one of the companies in the United States, companies in Construction Materials, companies in Materials, companies in Alsip and 3,456,808 companies in our database.
Talking Points
- Capstone Therapeutics Corp. is a clinical stage biotechnology company developing a family of new peptide drugs. $CAPS
- 1-10 employees Headquarters Tempe, Arizona Type Public Company Founded 2008 Locations 1275 West Washington St. Tempe, Arizona 85281, US Get directions Employees at Capstone Therapeutics Joan...
- Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.